Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

At 7% CAGR, Global Vulvodynia Treatment Market Size & Share Will Hit US$ 8 Billion by 2028 | Industry Trends, Demand, Growth, Value, Analysis & Forecast Report by Zion Market Research

This image opens in the lightbox

News provided by

Zion Market Research

12 Jul, 2022, 18:00 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, July 12, 2022 /PRNewswire/ -- As per Zion Market Research study, The global vulvodynia treatment market was worth around $5.4 billion in 2021 and is predicted to grow to around $8 billion by 2028 at a CAGR rate of 7% over the forecast period.

Key Industry Insights & Finding of the Vulvodynia Treatment Market  Reports:

  • As per the analysis shared by our research analyst, the Vulvodynia Treatment Market is expected to grow annually at a CAGR of around 7 % (2022-2028).
  • Through the primary research, it was established that the Vulvodynia Treatment Market was valued approximately USD 5.4 Billion in 2021 and is projected to reach to roughly USD 8 Billion by 2028.
  • Western Europe trails as the next best contributor of the market share owing to the growing popularity of vulvodynia treatment procedures.
  • The development activities and research going on in devising a suitable treatment method for vulvodynia trigger opportunities for market growth.
  • The limited awareness of the disease and the lack of effective treatment methods for the diseases restrain the market growth of vulvodynia treatment.
  • Growing trend of economic and financial burden because of the disease which boosts the demand for vulvodynia treatment. Multidisciplinary approaches in vulvodynia treatment also trigger market growth to a large extent.

Zion Market Research published the latest report titled as  "Vulvodynia Treatment Market By Type (Biofeedback Therapy, Intralesional Injections, and Oral Treatment), By Indication (Generalized Vulvodynia and Localized Vulvodynia), By End-Users (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028." into their research database.

Vulvodynia Treatment Market : Overview

Vulvodynia is vulvar pain or some kind of discomfort with respect to reproductive stages. All the comorbid symptoms and the pain associated with the disease will complicate any kind of movement or management. It also triggers some biological, psychological, and interpersonal factors that aggravate the illness to some extent.

The pain and discomfort increase while the vulva expands and contracts. That kind of movement is called vulvodynia. This problem is not easily diagnosable. The emergence of this condition affects a woman's life by disrupting her sex life and also her efforts to exercise. It is classified into two types such as generalized vulvodynia and localized vulvodynia.

It is usually caused due to improper tampon insertion, prolonged sitting, or horseback riding. Sometimes sexual intercourse or extreme gynecological examinations along with wearing tight undergarments can also cause this illness.

This occurs to women of all ages. Even though the disease is not fatal, this comes across as a life-disrupting illness that needs immediate cure or treatment. The reproductive health of women is also affected to some extent.

Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/vulvodynia-treatment-market

Our Free Sample Report Includes:

  • 2022 Updated Report Introduction, Overview, and In-depth industry analysis
  • COVID-19 Pandemic Outbreak Impact Analysis Included
  • 260 + Pages Research Report (Inclusion of Updated Research)
  • Provide Chapter-wise guidance on Request
  • 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes Updated List of tables & figures
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
  • Zion Market Research methodology

Industry Dynamics:

Vulvodynia Treatment Market : Growth Drivers

  • Growing focus on women's healthcare issues propels the market growth.

The major growth drivers of the global vulvodynia treatment market are the growing focus on women's healthcare and the awareness that has crept in recent times. There are multiple advancements in healthcare facilities to ease the treatment of vulvodynia to a great extent. This actually triggers huge demand for vulvodynia treatment thus making more people to opt for it. The access to the raw materials and generic products for the treatment methods are quite flexible and abundant thus improving the consumption of the treatment thereby inducing market growth.

Technological advancement in the field of vulvodynia treatment methods also improves its popularity. Many companies have now started focusing on bringing some technological advancements in the vulvodynia drug which propels growth in the market.

There is some growing awareness of the disease in recent times which seems to have increased its consumption. The growing knowledge amongst gynecologists is also supporting the market to a large extent. The growing leverage of anesthetics, lidocaine gels, and creams to reduce the pain also drives market growth exclusively.

Female sexual dysfunction has become a prominent problem and also awareness about it has increased in recent times. Pain killers for that illness have actually triggered more focus on the treatment method and medications have been prescribed in large quantities.

There is also a growing trend of economic and financial burden because of the disease which boosts the demand for vulvodynia treatment. Multidisciplinary approaches in vulvodynia treatment also trigger market growth to a large extent.

Vulvodynia Treatment Market : Restraints

  • Limited awareness of the disease and the side effects hamper market growth.

The limited awareness of the disease and the lack of effective treatment methods for the diseases restrain the market growth of vulvodynia treatment. Apart from this, the treatment is also touted to bring some considerable side effects because of the heavy medications used. All these factors curtail the expansion of the vulvodynia treatment market.        

Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/vulvodynia-treatment-market

Vulvodynia Treatment Market: Opportunities

  • Growing research on improving the treatment methods of vulvodynia offers the opportunity for market expansion.

The development activities and research going on in devising a suitable treatment method for vulvodynia trigger opportunities for market growth. Along with this, the therapeutic intervention and modification of drugs used in the process also greatly render global vulvodynia treatment market expansion opportunities.

Vulvodynia Treatment Market: Challenges

  • The lack of awareness of such a disease poses a challenge to the global market.

Many developing countries suffer from a lack of awareness and knowledge about this illness. The treatment methods and the lack of infrastructures & medical equipment needed for its cure are also in shortage in many regions. This factor acts as a challenge for the global market expansion and mass leverage.

  • Side effects of the treatment also challenge the market growth.

The treatment involves therapeutic intervention which appears to bring lots of side effects that affect people in different ways. This causes people to refuse treatment or a cure for this disease which in turn poses a challenge to market growth.

Global Vulvodynia Treatment Market : Segmentation

  • The global vulvodynia treatment market is fragmented into types, indications, end-users, and regions.

The type is classified into biofeedback therapy, intralesional injections, and oral treatment. The indication is divided into generalized vulvodynia and localized vulvodynia. The end users are hospital pharmacies, retail pharmacies, and online pharmacies.

Get More Insight before Buying@ : https://www.zionmarketresearch.com/inquiry/vulvodynia-treatment-market

List of Key Players of Vulvodynia Treatment Market :

  • Allergan plc
  • Johnson & Johnson Services Inc
  • Pfizer Inc
  • GlaxoSmithKline plc
  • AstraZeneca plc.
  • Eli Lilly
  • Sanofi
  • Hisamitsu Pharmaceutical Co. Inc
  • National Vulvodynia Association.

Key questions answered in this report:

  • What are the growth rate forecast and market size for Vulvodynia Treatment Market ?
  • What are the key driving factors propelling the Vulvodynia Treatment Market forward?
  • What are the most important companies in the Vulvodynia Treatment Market Industry?
  • What segments does the Vulvodynia Treatment Market cover?
  • How can I receive a free copy of the Vulvodynia Treatment Market sample report and company profiles?

Report Scope:

Report Attribute

Details

Market size value in 2021

USD 5.4 Billion

Revenue forecast in 2028

USD 8 Billion

Growth Rate

CAGR of almost 7 % 2022-2028

Base Year

2020

Historic Years

2016 - 2021

Forecast Years

2022 - 2028

Segments Covered

By Product Type, By Application, and By End Use

Forecast Units

Value (USD Billion), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2022 to 2028

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

Allergan plc, Johnson & Johnson Services Inc, Pfizer Inc, GlaxoSmithKline plc, AstraZeneca plc., Eli Lilly, Sanofi, Hisamitsu Pharmaceutical Co. Inc, and National Vulvodynia Association.

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail customized purchase options to meet your exact research needs.  

https://www.zionmarketresearch.com/custom/2437

Free Brochure: https://www.zionmarketresearch.com/requestbrochure/vulvodynia-treatment-market

Recent Developments

  • In June 2020, Allergen introduced vibrators to treat vulvodynia pelvic pains and also for more health benefits.
  • In Nov 2020, NIH-funded researchers developed a non-surgical treatment method for endometriosis and vulvodynia.

Regional Dominance:

  • The global market is likely to be dominated by North America during forecast period.

North America dominates the global vulvodynia treatment market due to the prevalence of these diseases and infertility issues. The research and ongoing development activities in this region also support market growth. Western Europe trails as the next best contributor of the market share owing to the growing popularity of vulvodynia treatment procedures. The growing medical research also improves the consumption of this treatment. There is a rapid progression of generic medications in the Asia Pacific region which makes it the third-most lucrative market contributor.

Global Vulvodynia Treatment Market  is segmented as follows:

Vulvodynia Treatment Market : By Type Outlook (2022-2028)

  • Biofeedback Therapy
  • Intralesional Injections
  • Oral Treatment

Vulvodynia Treatment Market : By Indication Outlook (2022-2028)

  • Generalized Vulvodynia
  • Localized Vulvodynia

Vulvodynia Treatment Market : By End User Outlook (2022-2028)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Vulvodynia Treatment Market : By Region Outlook (2022-2028)

North America

  • The U.S.
  • Canada

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Press Release For Vulvodynia Treatment Market : https://www.zionmarketresearch.com/news/global-vulvodynia-treatment-market

Browse Other Related Research Reports from Zion Market Research

  • Healthcare E-Commerce Market - Global Industry Analysis: The global Healthcare E-Commerce Market accrued earnings worth approximately 353.1 (USD Billion) in 2020 and is predicted to gain revenue of about 840.1 (USD Billion) by 2028, is set to record a CAGR of nearly 17.1% over the period from 2021 to 2028.
  • Immuno-Oncology Clinical Trials Market - Global Industry Analysis: The global Immuno-Oncology Clinical Trials Market accrued earnings worth approximately 5.4 (USD Billion) in 2020 and is predicted to gain revenue of about 15.6 (USD Billion) by 2028, is set to record a CAGR of nearly 13.7% over the period from 2021 to 2028.
  • AI-based Clinical Trials Solution Provider Market - Global Industry Analysis: AI-based Clinical Trials Solution Provider Market accrued earnings worth approximately 1.32 (USD Billion) in 2020 and is predicted to gain revenue of about 5.53(USD Billion) by 2028, is set to record a CAGR of nearly 22.1% over the period from 2021 to 2028.

Browse through Zion Market Research's coverage of the Global Healthcare Industry

Follow Us on: LinkedIn | Twitter | Facebook

About Us

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com/
Blog : https://techpru.com/ | http://thehealthypandas.com/

Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.